In a new attempt to prod action by HHS to lower the price of the opioid-reversing drug naloxone, Sen. Claire McCaskill (D-Mo.) asked HHS Secretary Alex Azar what the department has done since she grilled another HHS official on the issue earlier this year.
Source: Drug Industry Daily